Speaker: Boris Jordan, Chairman & CEO, Curaleaf Discussion Points • Why is Aurora the right target, among NASDAQ listed Canadian LPs • Why now? why not wait for S3 rescheduling and uplisting • Comparing cultivation scale and international RTM of the larger Canadian LPs • Mechanics of an OTC company buying a NASDAQ-listed operator? Plan to keep NASDAQ listing? • Will regulators in several countries have to approve the deal? • Plan B for Curaleaf if ACB bid fails • Could this trigger more Canada/US M&A? But more LP greater than MSO than MSO greater than LP #Curaleaf #ACB #AuroraCannabis #CannabisMerger #CannabisIndustry #MergersAndAcquisitions #CannabisNews Rss
